Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice.
about
Advanced vaccine candidates for Lassa feverVaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model systemVaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trialsA panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.Identification of protective Lassa virus epitopes that are restricted by HLA-A2.In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunityIn silico prediction of Ebola Zaire GP(1,2) immuno-dominant epitopes for the Balb/c mouse.Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse modelThe search for animal models for Lassa fever vaccine developmentHLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy.Generation of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation.Immune responses and Lassa virus infection.A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.
P2860
Q26823627-E6B45FEB-21D2-463B-8254-9165A55BDCBEQ33723534-3046B458-60B9-411D-A758-F0EBB1CF9CB6Q33909096-2B1F0871-CA51-4537-9581-05DBF8D73B70Q34671806-C11C70C3-3BD8-48E2-89C1-C2E58D03B8E8Q34815702-2DCC314D-4BD4-46BE-A4EA-B87D1B1A9B4FQ35024149-E021F24B-0922-4809-9124-5FC79F5E8450Q35198753-7CA5EFB5-BD68-4141-8A70-B7539FDFD85CQ35842756-340066B4-A033-4590-8FF6-50694E2ECC83Q36130780-75E2D003-2571-4864-8BE2-8C9B5E2CEBE5Q36581311-8BBECA93-FC87-43F0-8A5D-174F8D8EA8A0Q36588064-8E97636E-D4AC-4063-BC64-D795A00F7ECEQ36840281-D1C4C0FE-4D2E-4335-B142-A3BC25F9F75AQ37135201-5005492F-256D-4B79-AE72-3BADF4CD3881Q38064284-BAD10FE2-7194-4965-B09F-8161BBA6B400Q40040969-B714BBB9-E46F-434C-AE08-34406598E0C5
P2860
Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Lassa Fever Virus Peptides Pre ...... es in HLA-A2.1 Transgenic Mice
@nl
Lassa fever virus peptides pre ...... s in HLA-A2.1 transgenic mice.
@ast
Lassa fever virus peptides pre ...... s in HLA-A2.1 transgenic mice.
@en
type
label
Lassa Fever Virus Peptides Pre ...... es in HLA-A2.1 Transgenic Mice
@nl
Lassa fever virus peptides pre ...... s in HLA-A2.1 transgenic mice.
@ast
Lassa fever virus peptides pre ...... s in HLA-A2.1 transgenic mice.
@en
prefLabel
Lassa Fever Virus Peptides Pre ...... es in HLA-A2.1 Transgenic Mice
@nl
Lassa fever virus peptides pre ...... s in HLA-A2.1 transgenic mice.
@ast
Lassa fever virus peptides pre ...... s in HLA-A2.1 transgenic mice.
@en
P2860
P921
P1476
Lassa fever virus peptides pre ...... s in HLA-A2.1 transgenic mice.
@en
P2093
Agnieszka Boesen
Richard Coico
P2860
P304
P356
10.1128/CDLI.12.10.1223-1230.2005
P577
2005-10-01T00:00:00Z